IFR held its US ECM Roundtable on October 24 as stock market indices were nearing historic highs.
US equity capital markets have enjoyed a banner year in 2019, at least in terms of volume. Private unicorns have begun their long-awaited transition under the public markets, driving IPO volumes to new levels. Biotechs, a sub-sector of that transition, have found a good reception for their funding needs, and foreign companies are offering US investors a growing array of opportunities.